TPB Turning Point Brands, Inc.
Tobacco Products · NYSE · SEC CIK 1290677 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY23.8%
TTM net income YoY-47.7%
TTM EPS YoY-52.4%
Revenue 3-yr CAGR16.0%
Net income 3-yr CAGR31.6%
Margins
Gross margin58.4%
Operating margin10.9%
Net margin5.1%
FCF margin4.4%
EBITDA margin—
Returns
ROE7.1%
ROA3.4%
ROIC (approx.)11.8%
Asset turnover0.68x
Leverage & solvency
Liabilities / assets46.9%
Debt / equity0.70x
Current ratio5.83x
Interest coverage2.29x
Cash quality & payout
Operating cash flow / net income1.25x
Accruals ratio-0.9%
Payout ratio22.8%
Capex / revenue1.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $463.06M | $360.66M | $325.06M | $321.23M | $445.47M |
| Cost of revenue | $198.75M | $159.09M | $142.12M | $143.40M | $227.64M |
| Gross profit | $264.31M | $201.56M | $182.94M | $177.83M | $217.83M |
| R&D expense | $900,000 | $1.30M | $600,000 | $600,000 | $1.10M |
| SG&A expense | $168.99M | $122.41M | $104.33M | $103.82M | $127.51M |
| Operating income | $95.33M | $80.83M | $82.96M | $74.01M | $90.32M |
| Interest expense | $25.39M | $18.53M | $21.03M | $21.92M | — |
| Pretax income | $83.14M | $64.96M | $62.06M | $42.07M | $65.30M |
| Income tax | $14.99M | $16.93M | $24.00M | $10.98M | $14.04M |
| Net income | $58.16M | $39.81M | $38.46M | $11.64M | $52.06M |
| EBITDA | — | — | $89.32M | $79.31M | $95.33M |
| EPS (basic) | 3.18 | 2.24 | 2.19 | 0.65 | 2.75 |
| EPS (diluted) | 3.11 | 2.14 | 2.01 | 0.64 | 2.52 |
| Dividends declared per share | 0.30 | 0.28 | 0.26 | 0.24 | — |
| Weighted avg. shares (diluted) | 18.73M | 19.36M | 20.47M | 18.06M | 22.38M |
| Balance sheet | |||||
| Cash & equivalents | $222.76M | $48.94M | $117.89M | $106.40M | $128.32M |
| Receivables | $25.73M | $9.62M | $10.00M | $8.38M | $6.50M |
| Inventory | $107.99M | $96.25M | $91.70M | $119.92M | $87.61M |
| Current assets | $417.15M | $198.21M | $267.63M | $257.65M | $249.17M |
| PP&E, net | $36.25M | $26.34M | $25.14M | $22.79M | $18.65M |
| Goodwill | $136.10M | $135.93M | $136.25M | $136.25M | $162.33M |
| Intangibles | $64.04M | $65.25M | $66.49M | $83.59M | $87.48M |
| Total assets | $763.75M | $493.35M | $569.37M | $572.11M | $601.56M |
| Current liabilities | $75.01M | $44.82M | $100.35M | $41.38M | $40.34M |
| Short-term debt | — | $0 | $58.29M | $0 | — |
| Long-term debt | $293.62M | $248.60M | $307.06M | $406.76M | $414.17M |
| Total debt | $293.62M | $248.60M | $365.36M | $406.76M | $414.17M |
| Total liabilities | $391.77M | $302.97M | $417.36M | $458.73M | $467.84M |
| Shareholders' equity | $354.30M | $187.98M | $150.98M | $111.64M | $131.40M |
| Net debt | $70.86M | $199.66M | $247.47M | $300.35M | $285.85M |
| Cash flow statement | |||||
| Operating cash flow | $57.37M | $67.06M | $66.88M | $30.27M | $68.22M |
| Capital expenditure | $13.53M | $4.62M | $5.71M | $7.83M | $6.16M |
| Free cash flow | $43.84M | $62.44M | $61.17M | $22.44M | $62.06M |
| Investing cash flow | -$31.67M | -$10.51M | -$5.91M | -$18.79M | -$58.84M |
| Financing cash flow | $148.27M | -$128.28M | -$49.51M | -$43.30M | $57.07M |
| Depreciation & amortization | — | — | $6.36M | $5.30M | $5.01M |
| Stock-based compensation | $6.97M | $7.24M | $6.56M | $5.27M | $7.56M |
| Dividends paid | $5.52M | $4.91M | $4.50M | $4.25M | $4.10M |
| Share buybacks | $0 | $5.05M | $0 | $29.22M | $38.68M |
Free plan shows the latest 5 periods; Pro shows all 12 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.